Nicholas Ballay, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 719 Cook Dr, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 |
Preston W Brown, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 719 Cook Dr, Ste 109, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 |
Thomas S Layman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 719 Cook Dr, Suite 110, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 |
Michael P Sumida, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 719 Cook Dr, Ste 109, Athens, TN 37303 Phone: 423-745-2344 Fax: 423-745-2314 |
Harold Joseph Holliday, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1005 W Madison Ave, Athens, TN 37303 Phone: 423-744-7540 Fax: 423-745-4898 |
Charles Boggess Cox, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 503 W Madison Ave, Athens, TN 37303 Phone: 423-745-2312 Fax: 423-746-0687 |
News Archive
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods.
The Salt Lake Tribune: "Utah lawmakers this year have spared no energy trumpeting their dislike for federal health reform, passing bills asserting states' right to govern themselves. But Utah's own health care fix, an online insurance market called the Utah Health Exchange, has gotten off to a wobbly start. And legislation to repair it, sponsored by Republican House Speaker Dave Clark, came under siege last week. ...The debate left some reform advocates privately wondering if the topic has become too toxic to handle" (Stewart, 2/23).
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
Type 2 diabetes may be associated with brain degeneration, according to a new multicenter study published online in the journal Radiology. The study also found that, contrary to common clinical belief, diabetes may not be directly associated with small vessel ischemic disease, where the brain does not receive enough oxygenated blood.
› Verified 1 days ago